Back to search results

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Hemophilia A · Hemophilia B · Factor VII Deficiency

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Xiangya Hospital of Central South University, Changsha, China

  • The First Affiliated Hospital of University of Science and Technology of China, Hefei, China

  • Jinan Central Hospital, Jinan, China

  • The First Hospital of Lanzhou University, Lanzhou, China

  • Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China

  • The Second Hospital of Shanxi Medical University, Taiyuan, China

  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China

  • Xian Central Hospital, Xi'an, China

  • Zhengzhou People's Hospital, Zhengzhou, China

View source on ClinicalTrials.gov(opens in a new tab)